Litigation Details for IN RE SUBPOENA TO PING WANG v. GENENTECH, INC. (D.D.C. 2016)
✉ Email this page to a colleague
IN RE SUBPOENA TO PING WANG v. GENENTECH, INC. (D.D.C. 2016)
| Docket | ⤷ Try a Trial | Date Filed | 2016-09-26 |
| Court | District Court, District of Columbia | Date Terminated | 2016-10-13 |
| Cause | MS:MiscOrd | Assigned To | Colleen Kollar-Kotelly |
| Jury Demand | Referred To | ||
| Patents | 8,080,534 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in IN RE SUBPOENA TO PING WANG v. GENENTECH, INC.
The biologic drugs covered by the patent cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for IN RE SUBPOENA TO PING WANG v. GENENTECH, INC. (D.D.C. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-10-13 | 22 | leges infringement of its U.S. Patent No. 8,080,534 (“the ‘534 patent”) by Genentech. 3 Pet’rs’ 2…outside patent prosecution counsel to Phige- nix and as the attorney of record with the U.S. Patent and …discovery dispute is litigated in the underlying patent in- fringement action pending in the United States…and Trademark Office (“U.S. PTO”) for U.S. Patent Application No. 12/708,294 (“the ‘294 application”) that… that ultimately issued as the ‘534 patent. Id. Genentech has raised an inequitable conduct defense as | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
